COVID-19 vaccination protects people with B cell lymphoma and multiple myeloma

By | December 23, 2022
A recent Nature Cancer study documented that individuals with B cell lymphomas (LY) and multiple myeloma (MM) developed potent infection neutralization capabilities against several SARS-CoV-2 variants of concern (VoCs).